Skip to content

プレスリリース

Illumina to Present at the Piper Jaffray Health Care Conference

SAN DIEGO--(BUSINESS WIRE)--Nov. 23, 2011-- Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the company's presentation at the Piper Jaffray Health Care Conference in New York, New York, on November 30, 2011. The live webcast is scheduled to begin at 8:30 a.m. ET and will feature a brief overview of the company by Jay Flatley, President and Chief Executive Officer, followed by a question and answer session.

This webcast can be accessed in the Investor Relations section of Illumina's web site under the "Company" tab at www.illumina.com.

About Illumina

Illumina (http://www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA and protein. We also provide tools and services that are fueling advances in consumer genomics and diagnostics. Our technology and products accelerate genetic analysis research and its application, paving the way for molecular medicine and ultimately transforming healthcare.

Source: Illumina, Inc.

Illumina, Inc.
Investors:
Kevin Williams, MD
Investor Relations
858-332-4989
kwilliams@illumina.com
or
Media:
Laura Trotter
Public Relations
858-882-6822
PR@illumina.com

Recent Articles

Project Baby Bear – California Pilots Public Health Coverage for WGS
Project Baby Bear – California Pilots Public Health Coverage for WGS
Knowledge is Power: Unlocking the Potential of the Genome
Knowledge is Power: Unlocking the Potential of the Genome
Illumina Accelerator Invests in Four Startups for Ninth Cycle
Illumina Accelerator Invests in Four Startups for Ninth Cycle